News
HALB
0.0014
-12.50%
-0.0002
Weekly Report: what happened at HALB last week (1102-1106)?
Weekly Report · 6d ago
Weekly Report: what happened at HALB last week (1026-1030)?
Weekly Report · 11/02 09:19
Weekly Report: what happened at HALB last week (1019-1023)?
Weekly Report · 10/26 09:19
Weekly Report: what happened at HALB last week (1012-1016)?
Weekly Report · 10/19 09:19
Weekly Report: what happened at HALB last week (1005-1009)?
Weekly Report · 10/12 09:20
Weekly Report: what happened at HALB last week (0928-1002)?
Weekly Report · 10/05 09:20
Weekly Report: what happened at HALB last week (0921-0925)?
Weekly Report · 09/28 09:19
Weekly Report: what happened at HALB last week (0914-0918)?
Weekly Report · 09/21 09:19
Weekly Report: what happened at HALB last week (0907-0911)?
Weekly Report · 09/14 09:20
Weekly Report: what happened at HALB last week (0831-0904)?
Weekly Report · 09/07 09:19
Weekly Report: what happened at HALB last week (0824-0828)?
Weekly Report · 08/31 09:20
Weekly Report: what happened at HALB last week (0817-0821)?
Weekly Report · 08/24 09:21
Weekly Report: what happened at HALB last week (0810-0814)?
Weekly Report · 08/17 09:21
Weekly Report: what happened at HALB last week (0803-0807)?
Weekly Report · 08/10 09:20
Weekly Report: what happened at HALB last week (0727-0731)?
Weekly Report · 08/03 09:20
Weekly Report: what happened at HALB last week (0720-0724)?
Weekly Report · 07/27 09:21
Weekly Report: what happened at HALB last week (0713-0717)?
Weekly Report · 07/20 09:20
Weekly Report: what happened at HALB last week (0706-0710)?
Weekly Report · 07/13 09:20
Weekly Report: what happened at HALB last week (0629-0703)?
Weekly Report · 07/06 09:21
Weekly Report: what happened at HALB last week (0622-0626)?
Weekly Report · 06/29 09:20
More
Webull provides a variety of real-time HALB stock news. You can receive the latest news about Halberd Corp through multiple platforms. This information may help you make smarter investment decisions.
About HALB
Halberd Corporation is a technology holding company. The Company is focused on developing solutions for healthcare and medical applications. Its portfolio includes approaches to disease treatment, diagnostic technologies, and artificial intelligence (AI)-powered healthcare platforms. It has acquired licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and cerebrospinal fluid-related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its subsidiary, NeuroSense AI Corp., is a behavioral intelligence platform in development combining AI with multi-modal sensor technology that integrates ultrasonic vocalization analysis, micro-movement tracking, and social behavior monitoring through Claude AI-powered interpretation to provide unprecedented insights into brain health and recovery patterns. Its subsidiaries also include Alaric Corporation and Extendalife, Inc.